- Home
- REI vs OBIO Comparison
REI vs OBIO Comparison
Compare REI & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | REI | OBIO |
|---|---|---|
| Founded | 2004 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medicinal Chemicals and Botanical Products |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 206.5M | 172.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | REI | OBIO |
|---|---|---|
| Price | $0.92 | $4.25 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $13.67 |
| AVG Volume (30 Days) | ★ 1.5M | 332.9K |
| Earning Date | 11-06-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $308,790,652.00 | $2,818,000.00 |
| Revenue This Year | N/A | $36.43 |
| Revenue Next Year | $2.43 | $2.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 6.46 |
| 52 Week Low | $0.72 | $2.20 |
| 52 Week High | $1.55 | $6.30 |
Technical Indicators
Market Signals| Indicator | REI | OBIO |
|---|---|---|
| Relative Strength Index (RSI) | 45.46 | 46.26 |
| Support Level | $0.86 | $4.15 |
| Resistance Level | $0.97 | $5.42 |
| Average True Range (ATR) | 0.04 | 0.37 |
| MACD | 0.00 | -0.11 |
| Stochastic Oscillator | 48.40 | 3.92 |
Price Performance
Historical ComparisonAbout REI Ring Energy Inc.
Ring Energy Inc is an independent exploration and production company based in The Woodlands, Texas and is engaged in oil and natural gas development, production, acquisition, and exploration activities currently focused in the Permian Basin of Texas. The drilling operations of the company target the oil and liquid rich producing formations in the Northwest Shelf, the Central Basin Platform and the Delaware Basin all of which are part of the Permian Basin in Texas.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.